Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Other Non-Current Assets (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Other Non-Current Assets for 7 consecutive years, with $24.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 41.44% to $24.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Dec 2025, down 41.44% year-over-year, with the annual reading at $24.0 million for FY2025, 41.44% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $24.0 million at Strata Critical Medical, up from $8.6 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $41.0 million in Q4 2024, with the low at $415000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $4.8 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets surged 2825.46% in 2024, then tumbled 41.44% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $630000.0 in 2021, then surged by 115.87% to $1.4 million in 2022, then grew by 3.09% to $1.4 million in 2023, then soared by 2825.46% to $41.0 million in 2024, then crashed by 41.44% to $24.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $24.0 million, $8.6 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.